| Primary |
| Osteoporosis |
36.8% |
| Product Used For Unknown Indication |
27.5% |
| Drug Use For Unknown Indication |
8.0% |
| Osteoporosis Prophylaxis |
4.9% |
| Osteoarthritis |
2.6% |
| Systemic Lupus Erythematosus |
2.6% |
| Migraine |
2.3% |
| Prophylaxis |
2.3% |
| Rheumatoid Arthritis |
2.1% |
| Asthma |
1.8% |
| Osteopenia |
1.8% |
| Ill-defined Disorder |
1.5% |
| Spinal Compression Fracture |
1.0% |
| Bone Density Decreased |
0.8% |
| Breast Cancer |
0.8% |
| Deep Vein Thrombosis |
0.8% |
| Epilepsy |
0.8% |
| Hypothyroidism |
0.8% |
| Acute Myocardial Infarction |
0.5% |
| Osteonecrosis |
0.5% |
|
| Femur Fracture |
19.8% |
| Osteonecrosis Of Jaw |
9.4% |
| Atrial Fibrillation |
6.3% |
| Vision Blurred |
6.3% |
| Dyspnoea |
4.2% |
| Fall |
4.2% |
| Haematemesis |
4.2% |
| Osteonecrosis |
4.2% |
| Stress Fracture |
4.2% |
| Weight Decreased |
4.2% |
| Wrist Fracture |
4.2% |
| Wrong Technique In Drug Usage Process |
4.2% |
| Aplastic Anaemia |
3.1% |
| Arterial Haemorrhage |
3.1% |
| Drug Ineffective |
3.1% |
| Epistaxis |
3.1% |
| Impaired Healing |
3.1% |
| Myalgia |
3.1% |
| Oesophageal Adenocarcinoma |
3.1% |
| Oesophageal Ulcer |
3.1% |
|
| Secondary |
| Product Used For Unknown Indication |
21.5% |
| Osteoarthritis |
12.5% |
| Migraine |
11.8% |
| Asthma |
8.3% |
| Ill-defined Disorder |
8.3% |
| Drug Use For Unknown Indication |
6.9% |
| Systemic Lupus Erythematosus |
4.9% |
| Deep Vein Thrombosis |
4.2% |
| Epilepsy |
4.2% |
| Hypothyroidism |
4.2% |
| Rheumatoid Arthritis |
3.5% |
| Hypertension |
2.1% |
| Osteoporosis |
2.1% |
| Bone Disorder |
1.4% |
| Constipation |
0.7% |
| Gout |
0.7% |
| Intermittent Claudication |
0.7% |
| Myalgia Intercostal |
0.7% |
| Osteoporosis Prophylaxis |
0.7% |
| Pain |
0.7% |
|
| Dyspnoea |
20.8% |
| Panic Attack |
8.3% |
| Toxicity To Various Agents |
8.3% |
| Urinary Tract Infection |
8.3% |
| Arthralgia |
4.2% |
| Circulatory Collapse |
4.2% |
| Duodenal Ulcer Haemorrhage |
4.2% |
| Gastric Ulcer Haemorrhage |
4.2% |
| Inappropriate Schedule Of Drug Administration |
4.2% |
| Intentional Drug Misuse |
4.2% |
| Maternal Drugs Affecting Foetus |
4.2% |
| Rectal Haemorrhage |
4.2% |
| Scab |
4.2% |
| Syncope |
4.2% |
| Upper Gastrointestinal Haemorrhage |
4.2% |
| Wheezing |
4.2% |
| White Blood Cell Count Increased |
4.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.4% |
| Depression |
11.2% |
| Drug Use For Unknown Indication |
8.2% |
| Hypertension |
7.1% |
| Back Pain |
4.1% |
| Dementia Alzheimer's Type |
4.1% |
| Hiv Test Positive |
4.1% |
| Pain |
4.1% |
| Pneumonia |
4.1% |
| Psychotic Disorder |
4.1% |
| Cerebrovascular Accident |
3.1% |
| Chronic Lymphocytic Leukaemia |
3.1% |
| Diffuse Vasculitis |
3.1% |
| Osteoporosis |
3.1% |
| Prophylaxis |
3.1% |
| Urinary Tract Infection |
3.1% |
| Cardiac Failure |
2.0% |
| Cellulitis |
2.0% |
| Dementia |
2.0% |
| Idiopathic Pulmonary Fibrosis |
2.0% |
|
| Treatment Failure |
11.1% |
| Liver Function Test Abnormal |
6.7% |
| Renal Impairment |
6.7% |
| Drug Interaction |
4.4% |
| Hallucination |
4.4% |
| Heart Transplant |
4.4% |
| Hypotension |
4.4% |
| Increased Tendency To Bruise |
4.4% |
| Lethargy |
4.4% |
| Lower Respiratory Tract Infection |
4.4% |
| Malaise |
4.4% |
| Mouth Ulceration |
4.4% |
| Myositis |
4.4% |
| Orthostatic Hypotension |
4.4% |
| Pain |
4.4% |
| Pruritus |
4.4% |
| Rash Generalised |
4.4% |
| Renal Failure Acute |
4.4% |
| Respiratory Failure |
4.4% |
| Rhinitis Allergic |
4.4% |
|
